Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk

Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk

The classic description of diabetic kidney disease (DKD) involves progressive stages of glomerular hyperfiltration, microalbuminuria, proteinuria, and a decline in the estimated glomerular filtration rate (eGFR), leading to dialysis. In recent years, this concept has been increasingly challenged as...

Full description

Bibliographic Details
Main Authors:	Sabrina Scilletta, Maurizio Di Marco, Nicoletta Miano, Agnese Filippello, Stefania Di Mauro, Alessandra Scamporrino, Marco Musmeci, Giuseppe Coppolino, Francesco Di Giacomo Barbagallo, Giosiana Bosco, Roberto Scicali, Salvatore Piro, Francesco Purrello, Antonino Di Pino
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Biomolecules
Subjects:	chronic complications of type 2 diabetes diabetic kidney disease cardiovascular risk non-albuminuric diabetic kidney disease
Online Access:	https://www.mdpi.com/2218-273X/13/5/752

Similar Items

Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease
by: Maurizio Di Marco, et al.
Published: (2023-12-01)

Co-differential genes between DKD and aging: implications for a diagnostic model of DKD
by: Hongxuan Du, et al.
Published: (2024-02-01)

The Role of Immune Cells in DKD: Mechanisms and Targeted Therapies
by: Peng QY, et al.
Published: (2024-04-01)

Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials
by: John M. Flack, et al.
Published: (2023-12-01)

Non-Albumin Proteinuria (NAP) as a Complementary Marker for Diabetic Kidney Disease (DKD)
by: Jaehyun Bae, et al.
Published: (2021-03-01)

Cardiometabolic traits mediating the effect of education on the risk of DKD and CKD: a Mendelian randomization study
by: Yukai Wang, et al.
Published: (2024-08-01)

Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives
by: Daniela Maria Tanase, et al.
Published: (2022-09-01)

Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: The FIDELIO-DKD Subgroup from China
by: Haitao Zhang, et al.
Published: (2023-08-01)

Serum osteocalcin levels are inversely associated with UACR in Chinese DKD patients: a meta-analysis of 20 clinical studies
by: Xiaolan Hu, et al.
Published: (2024-12-01)

The Effect of Autologous Dendritic Cell Immunotherapy on Kidney Function and Endothelial Dysfunction of Patients with Diabetic Kidney Disease (DKD): An Open Label Clinical Trial
by: Martina Lily Yana, et al.
Published: (2025-01-01)

Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels
by: Stefania Capuccio, et al.
Published: (2024-06-01)

Serum advanced glycation end products as a putative biomarker in Type2 DKD patients’ prognosis
by: Ze-Hou Wang, et al.
Published: (2025-01-01)

Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation
by: Xianhong Li, et al.
Published: (2024-03-01)

Open-Label Clinical Trial on the Impact of Autologous Dendritic Cell Therapy on Albuminuria and Inflammatory Biomarkers (Interleukin-6, Interleukin-10, Tumor Necrosis Factor α) in Diabetic Kidney Disease (DKD)
by: Jonny, et al.
Published: (2024-12-01)

The role of kidney biopsy in deciphering diabetic versus non-diabetic origin of kidney disease among patients with type 2 diabetes mellitus and nephrotic range proteinuria: A retrospective study
by: Efstratios Kardalas, et al.
Published: (2024-09-01)

Serum adropin levels as a potential biomarker for predicting diabetic kidney disease progression
by: I-Wen Chen, et al.
Published: (2025-02-01)

Plasma Asprosin Concentrations are Associated with Progression of Diabetic Kidney Disease
by: Xu M, et al.
Published: (2024-06-01)

Nomenclature of renal involvement in diabetes mellitus: unify to manage diversity
by: María Marques, et al.
Published: (2025-03-01)

Potential Role of Copper in Diabetes and Diabetic Kidney Disease
by: Guido Gembillo, et al.
Published: (2022-12-01)

The state of kidney replacement therapy in Eastern Cape Province, South Africa: A call to action
by: L Mtingi-Nkonzombi, et al.
Published: (2023-03-01)

Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus
by: Yu-Ling Lin, et al.
Published: (2025-01-01)

The effectiveness of antioxidant agents in delaying progression of diabetic nephropathy: A systematic review of randomized controlled trials
by: Ika Rahayu, et al.
Published: (2024-06-01)

Insulin and the kidneys: a contemporary view on the molecular basis
by: Rodrigo Daza-Arnedo, et al.
Published: (2023-08-01)

A Role for Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Chronic Kidney Disease: A Mini Review
by: Jinfang Song, et al.
Published: (2023-09-01)

Factores de progresión en pacientes con ERC-3 KDOQI (estudio PROGRESER)
by: Alberto Martínez-Castelao, et al.
Published: (2024-09-01)

A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes
by: van Zuydam, Natalie R., et al.
Published: (2020)

The impact of social deprivation on development and progression of diabetic kidney disease [version 1; peer review: 2 approved]
by: Patricia M Kearney, et al.
Published: (2024-08-01)

The Role of Autophagy in Type 2 Diabetic Kidney Disease Management
by: Che-Hao Tseng, et al.
Published: (2023-11-01)

Novel Markers in Diabetic Kidney Disease—Current State and Perspectives
by: Agnieszka Piwkowska, et al.
Published: (2022-05-01)

Characterization of diabetic kidney disease in 235 patients: clinical and pathological insights with or without concurrent non-diabetic kidney disease
by: Mengjie Jiang, et al.
Published: (2025-01-01)

Pathophysiological features of thyroid dysfunction in patients with type 2 diabetes and chronic kidney disease (a literature review and own observations)
by: A.M. Urbanovych, et al.
Published: (2023-12-01)

Treatment and practical considerations of diabetic kidney disease
by: Yara Bilen, et al.
Published: (2023-12-01)

Clinical characteristics and prognostic analysis of patients with type 2 diabetic kidney disease and non-diabetic kidney disease
by: Can Yu, et al.
Published: (2025-03-01)

Study of clinical and histopathological factors predicting rapid progression in biopsy-proven type 2 diabetic kidney disease
by: Shilna Muttickal Swaminathan, et al.
Published: (2024-08-01)

Diabetic Kidney Disease in Post-Transplant Diabetes Mellitus: Causes, Treatment and Outcomes
by: Lee-Moay Lim, et al.
Published: (2023-02-01)

The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia
by: Giosiana Bosco, et al.
Published: (2024-02-01)

The Pillars for Renal Disease Treatment in Patients with Type 2 Diabetes
by: Jessica Kearney, et al.
Published: (2023-04-01)

Association of a low ankle brachial index with progression to end-stage kidney disease in patients with advanced-stage diabetic kidney disease
by: Ruiying Tang, et al.
Published: (2023-12-01)

Progression and regression of kidney disease in type 1 diabetes
by: Fanny Jansson Sigfrids, et al.
Published: (2023-12-01)

Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024
by: Sagen Zac-Varghese, et al.
Published: (2024-07-01)